| Photodynamic therapy–mechanisms, photosensitizers and combinations S Kwiatkowski, B Knap, D Przystupski, J Saczko, E Kędzierska, ... Biomedicine & pharmacotherapy 106, 1098-1107, 2018 | 1769 | 2018 |
| Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA MF Bozkurt, I Virgolini, S Balogova, M Beheshti, D Rubello, C Decristoforo, ... European journal of nuclear medicine and molecular imaging 44, 1588-1601, 2017 | 451 | 2017 |
| The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer F Giammarile, N Alazraki, JN Aarsvold, RA Audisio, E Glass, SF Grant, ... European journal of nuclear medicine and molecular imaging 40, 1932-1947, 2013 | 313 | 2013 |
| Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option? J Kunikowska, L Królicki, A Hubalewska-Dydejczyk, R Mikołajczak, ... European journal of nuclear medicine and molecular imaging 38, 1788-1797, 2011 | 261 | 2011 |
| Consensus on molecular imaging and theranostics in neuroendocrine neoplasms V Ambrosini, J Kunikowska, E Baudin, L Bodei, C Bouvier, J Capdevila, ... European journal of cancer 146, 56-73, 2021 | 175 | 2021 |
| Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) B Kos-Kudła, J Blicharz-Dorniak, J Strzelczyk, A Bałdys-Waligórska, ... Endokrynologia Polska 68 (2), 79-110, 2017 | 120 | 2017 |
| Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue L Krolicki, F Bruchertseifer, J Kunikowska, H Koziara, B Królicki, ... European journal of nuclear medicine and molecular imaging 45, 1636-1644, 2018 | 99 | 2018 |
| Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma L Królicki, F Bruchertseifer, J Kunikowska, H Koziara, B Królicki, ... European journal of nuclear medicine and molecular imaging 46, 614-622, 2019 | 95 | 2019 |
| What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions? J Kunikowska, R Matyskiel, S Toutounchi, L Grabowska-Derlatka, ... European journal of nuclear medicine and molecular imaging 41, 2273-2280, 2014 | 68 | 2014 |
| Statins impair glucose uptake in tumor cells A Malenda, A Skrobanska, T Issat, M Winiarska, J Bil, B Oleszczak, ... Neoplasia 14 (4), 311-323, 2012 | 66 | 2012 |
| [68Ga] Ga-PSMA versus [18F] PSMA positron emission tomography/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature L Evangelista, T Maurer, H van der Poel, F Alongi, J Kunikowska, ... European Urology Oncology 5 (3), 273-282, 2022 | 63 | 2022 |
| Semiquantitative analysis and characterization of physiological biodistribution of 68Ga-DOTA-TATE PET/CT J Kunikowska, L Królicki, D Pawlak, I Zerizer, R Mikolajczak Clinical nuclear medicine 37 (11), 1052-1057, 2012 | 63 | 2012 |
| 68Ga–Prostate-Specific Membrane Antigen-11 PET/CT: A New Imaging Option for Recurrent Glioblastoma Multiforme? J Kunikowska, R Kuliński, K Muylle, H Koziara, L Królicki Clinical Nuclear Medicine 45 (1), 11-18, 2020 | 61 | 2020 |
| Colorectal neuroendocrine neoplasms—management guidelines (recommended by the Polish Network of Neuroendocrine Tumours) T Starzyńska, M Londzin-Olesik, A Bałdys-Waligórska, T Bednarczuk, ... Endokrynologia Polska 68 (2), 250-260, 2017 | 61 | 2017 |
| Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the … J Kunikowska, D Pawlak, MI Bąk, B Kos-Kudła, R Mikołajczak, L Królicki Annals of Nuclear Medicine 31, 347-356, 2017 | 60 | 2017 |
| Targeted α-emitter therapy of neuroendocrine tumors J Kunikowska, L Królicki Seminars in nuclear medicine 50 (2), 171-176, 2020 | 53 | 2020 |
| Pancreatic neuroendocrine neoplasms—management guidelines (recommended by the Polish Network of Neuroendocrine Tumours) B Kos-Kudła, V Rosiek, M Borowska, A Bałdys-Waligórska, T Bednarczuk, ... Endokrynologia Polska 68 (2), 169-197, 2017 | 53 | 2017 |
| Repeated cycles of peptide receptor radionuclide therapy (PRRT)–results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in … D Pach, A Sowa-Staszczak, J Kunikowska, L Królicki, M Trofimiuk, ... Radiotherapy and Oncology 102 (1), 45-50, 2012 | 52 | 2012 |
| Diagnostic performance and clinical impact of 68Ga-PSMA-11 PET/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA Study) JJ Cerci, S Fanti, EE Lobato, J Kunikowska, O Alonso, S Medina, ... Journal of Nuclear Medicine 63 (2), 240-247, 2022 | 51 | 2022 |
| 225Ac-and 213Bi-substance P analogues for glioma therapy L Królicki, J Kunikowska, F Bruchertseifer, H Koziara, B Królicki, ... Seminars in nuclear medicine 50 (2), 141-151, 2020 | 47 | 2020 |
